Misti Ushio, former CEO of TARA Biosystems acquired by Valo Health, explains the genesis of her lab-engineered, mature, functioning human heart tissue company, why pharma R&D teams need access to biology-in-a-dish and the data it can generate, and how she sees the future of the organ-on-a-chip space.

Learn more about TARA's acquisition by Valo Health at https://www.alantra.com/ib-transaction/tara-sell-side-advisory-valo-health/